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and La Chaux-de-Fonds (population of 55’000 people). The anonymous
questionnaire, presenting the 10 EULAR and 25 OARSI recommendations
for the treatment of hip and knee OA, asked for some demographic data
of the physicians and for the knowledge and acceptance of the presented
recommendations.
Results: They were expressed as a “strength of acceptance” (SoA), based
on a semi-quantitative evaluation (1 to 5/5) and expressed in percent for
comparison to the “strength of recommendation” (SoR) reported by EULAR
and OARSI.Twenty-three questionnaires (41%) were returned. Seven of the
ten GP, one of the six IM, one of the four ORTHO who responded and the
three RHEUMATO knew and applied some of the EULAR recommendations.
Only one GP, one ORTHO and one RHEUMATO knew the OARSI recom-
mendations. The SoA was a little less for the primary care physicians (GP
+ IM) than for the specialists in the musculoskeletal diseases (ORTHO +
RHEUMATO) for the EULAR (85 versus 89%) and for the OARSI (73 versus
78%) recommendations. None of the EULAR or OARSI recommendations
gained a full SoA by the primary care physicians although two EULAR and
one OARSI recommendations obtained a complete SoA by the specialists in
the musculoskeletal diseases.
Conclusions: In this sample of physicians, most IM and ORTHO ignored the
EULAR and OARSI recommendations for the treatment of hip or knee OA.
Nonetheless, a majority of primary care physicians and specialists in the
musculoskeletal diseases adhered to the most of them with occasionally a
greater SoA than the proposed SoR. An effort for a better diffusion of these
recommendations is justiﬁed among IM and ORTHO.
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Purpose: Infection comprises a potentially serious complication following
joint replacement surgery as a result of osteoarthtritis, and also poses
an even greater challenge to the health care in view of the number of
severe bone, joint and soft tissue suppurations accompanying high-energy
injuries.
The treatment of these infections is based on appropriately radical surgical
debridement and long - lasting speciﬁed parenteral antibiotic therapy.
The material most commonly used for local antibiotic therapy is a bone
cement, compounded from a liquid monomer and a mixture of solid
methyl and methacrylate PMMA components. As polymerization proceeds
in the patient as an endothermic reaction at a temperature sometimes
exceeding 100°C, the added antibiotics should be heat-resistant and must
not inﬂuence the mechanical characteristics of the PMMA.
The aim of our research work was to develop an injectable drug - delivery
system that forms an elastic gel within a short time after its injection into
joints, bone cavities or subcutaneous tissues, prevented from ﬂowing out
by virtue of its high viscosity, while the drug release is controlled by the
biodegradable polymer network.
Methods: Sodium alginate was chosen as a natural polymer which has
been widely investigated for drug delivery. It also has the potential for use
as a scaffolding material for tissue engineering because of its structural
similarity to the natural extracellular matrix, its gentle gelling kinetics, and
its low toxicity when puriﬁed.
Oﬂoxacin, selected as active agent at a concentration of 3%, is a synthetic
broad-spectrum antimicrobial agent for oral and intravenous administra-
tion, with an in vitro activity against a broad spectrum of Gram-positive
and Gram-negative aerobic and anaerobic bacteria. Crosslinking of the vis-
cous - ﬂowing sodium alginate mucilage was carried out ex tempore with
calcium-sulphate in the presence of ethylenediaminetetraacetate (EDTA),
using two injection syringes joined by a thin tube. Rheological measure-
ments to ﬁnd the suitable hydrogel delivery systems were carried out with
a Paar Physica MCR 101 rheometer. An in vitro Franz vertical cell diffusion
drug release test and in vitro microbiological evaluation of the drug release
via the Kirby-Bauer disk diffusion method were performed.
Results: As a result of crosslinking, a marked increase in viscosity was
observed, which proved suitable for our application purposes. Release
from the more viscous hydrogel containing 3% sodium alginate was more
delayed than that from the 2% sodium alginate - containing gel. However,
considering the effect of water content on the diameter of inhibition zones
it can be concluded, that the higher viscosity led to the formation of
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wider inhibition zones. Microbiological evaluation of the antibiotic release
disclosed that antibiotic was released from the discs in all cases.
Conclusions: Oﬂoxacin released effectively from the crosslinked calcium
alginate, and increased the inhibitory zones around the hydrogel discs.
It seemed to be effective against most pathogens with a resistance to
other antibiotics, emerging in our orthopaedic clinical practice in recent
years. The present results suggest that such crosslinked calcium alginate
hydrogels are good candidates for replacement of the currently used
non-biodegradable bone cements with high polymerization temperature in
certain orthopedic surgical interventions.
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Purpose: To evaluate the potential anti-inﬂammatory activity in vitro, as
well as the absorption of a natural extract from rooster comb (Hyal-Joint®).
Methods: Two in vitro assays were performed to determine the potential
activity of Hyal-Joint®. The effect on inﬂammation was determined by us-
ing human dermal ﬁbroblasts stimulated with IL-1β and co-treated with 3
concentrations of the nutraceutical extract (5, 50 and 500 μg/ml). Levels of
Prostaglandin E2 (PGE2) and Metalloprotease-1 (MMP-1) were determined
by EIA. The compound NS 398 at 1 μM was used as a positive control of
cyclooxygenase-2 (Cox-2) inhibition in this assay.
The absorption of the extract was determined using the everted gut sac
model in rats. Male OFA-strain rats weighing around 200g were sacriﬁced
by cervical dislocation and segments of 4cm of jejunum, duodenum and
ileum were removed, rinsed with Krebs-Henseleit solution and everted.
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The segments were tied at one end, ﬁlled with Krebs-Henseleit solution,
and then tied at the other end. Each sac was individually placed in a 20 ml
glass tube containing oxygenated Krebs Henseleit solution with Hyal-Joint®
at a ﬁnal concentration of 200 μg/ml and was incubated at 37°C. The whole
samples of the inside medium were taken at 5, 10, 20 and 30 minutes. The
amount of Hyal-Joint® absorbed was determined following the technique
described by Farndale et al (1982) for glycosaminoglycan determination.
Results: The compound Hyal-Joint® was able to reduce in vitro the PGE2
and MMP-1 levels induced by the inﬂammatory cytokine IL-1β. In the
case of PGE2, Hyal-Joint® inhibited 70, 47 and 49% the PGE2 production
at 500, 50 and 5 μg/ml, respectively, and thus inhibits Cox-2 activity. In
addition this compound inhibits the IL-1β-induced production of MMP-1 at
all concentrations, being more effective at 5 μg/ml than at 500 μg/ml.
The study of absorption showed that the extract was absorbed from the
medium through the intestinal mucous membrane. The absorption was
higher in the duodenum (38%), and subsequently in the jejunum (22%) and
ileum (9%).
Conclusions: The present study indicates that Hyal-Joint® has anti-
inﬂammatory effects and is absorbed well through the intestine. Thus, the
natural compound Hyal-Joint® may be useful as a nutritional supplement
for maintaining joint integrity and function.
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Purpose: Patients undergoing total hip replacement surgery due to pri-
mary or secondary osteoarthritis in their hip occationally need revision
surgery because of a periprosthetic deep tissue infection. In most cases,
these patients undergo a 2-stage procedure, that consists of a temporary
antibiotic containing polymethylmethacrylate (PMMA) spacer insertion and
later implantation of a new permanent hip prosthesis. The aim of our study
was to examine the microscopic structure and the elemental composition
of such an antibiotic containing PMMA hip spacer after removal from the
patient.
Methods: For the investigation we have used a gentamicin containing
PMMA spacer which has spent 45 days in a patinent’s right hip joint after
removal of an infected implant. We have carried out scanning electron
microscopy combined with energy-dispersive X-ray spectroscopic analysis
(SEM/EDS) to image and identify the building blocks of the spacer material.
With X-ray ﬂuorescence analysis we have measured the sulphur content
on surfaces of segments from different depths within our specimen in
order to estimate their gentamicin sulphate concentration. Finally, we have
performed scanning electronmicroscope (SEM) imaging in the same depths
to visualise changes of the gentamicin particles both in deep and superﬁcial
layers of PMMA matrix.
Results: SEM/EDS analysis has revealed the location and shape of PMMA,
gentamicin and barium-sulphate particles in the spacer matrix, and has




sample. X-ray ﬂuorescence analysis has detected a gradually declining
gentamicin sulphate concentration from the center to the surface of the
specimen. The corresponding SEM ﬁndings have shown many voids visible
at lower magniﬁcation. Gap was visible between gentamicin particles and
PMMA matrix both on samples from superﬁcial and deep-lying parts of the
spacer.
Figure 4
Conclusions: Voids visible at lower magniﬁcation on SEM micrographs
resulted from conventional manual mixing technique, and may have con-
tributed to gaps between gentamicin particles and PMMA matrix both
on samples from superﬁcial and deep-lying parts of the sample. Lower
concentration of gentamicin sulphate close to the spacer surface means that
diffusion closer to body ﬂuids was more effective in removing gentamicin
from the spacer matrix. Since calcium cannot be detected in the control
sample, we can assume that it has moved into the spacer material by
diffusion from body ﬂuids or bone tissue that surrounded the sample
during the 45 days spent in the human body. More investigation is needed
to reveal the role and extent of calcium migration into the deeper-lying
parts of the implanted bone cement.
